Glenmark Pharmaceuticals informs about company updates

01 Jun 2016 Evaluate

Glenmark Pharmaceuticals has informed that in furtherance to the notice issued by the Company on May 31, 2016 announcing the launch of the FCCBs, the Company has entered into a Subscription Agreement dated May 31, 2016 with J.P. Morgan Securities plc (the book running lead manager to the Issue). In terms of the Subscription Agreement, the Company will issue the FCCBs at 100% of their principal amount on or about June 28, 2016 (Closing Date).

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2023.85 -12.05 (-0.59%)
01-Jan-2026 10:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1713.05
Dr. Reddys Lab 1251.30
Cipla 1503.05
Zydus Lifesciences 909.40
Lupin 2083.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×